Intelligent computation in cancer gene therapy.

Area of Science:

• Biotechnology
• Synthetic Biology
• Computational Biology

Background:

• Gene therapy shows promise but requires real-time control of gene expression for safety and efficacy.
• Early gene therapy trials highlighted the need for advanced control mechanisms to target diseases precisely.
• Synthetic biology provides tools like synthetic gene circuits to address these control challenges.

Purpose of the Study:

• To review computational approaches for implementing artificial intelligence within living cells.
• To explore the use of synthetic gene regulatory networks and artificial neural networks for cancer gene therapy.
• To discuss current advancements in computational methods for smart cell development.

Main Methods:

• Review of computational strategies for in vivo artificial intelligence.
• Focus on implementing artificial neural networks via synthetic gene regulatory networks.
• Analysis of state-of-the-art computational developments in synthetic biology for therapeutic applications.

Main Results:

• Synthetic gene circuits enable the creation of "smart cells" with fine-tuned gene expression.
• Artificial intelligence approaches can be integrated into cellular systems for targeted therapies.
• Computational methods are advancing the development of safer and more effective gene therapies.

Conclusions:

• Integrating artificial intelligence into gene therapy holds significant potential for treating diseases like cancer.
• Synthetic biology and computational approaches are crucial for developing next-generation, precise gene therapies.
• Further development of computational tools is essential for realizing the full potential of AI-driven cellular therapies.